Montelukast improves disease outcome in SOD1^G93A female mice by counteracting oligodendrocyte dysfunction and aberrant glial reactivity

Abstract

Our results provide the first preclinical evidence indicating that repurposing of MTK, a safe and marketed anti-asthmatic drug, may be a promising sex-specific strategy for personalized ALS treatment.